Skip to main content

Fco. Javier Muñoz Gall

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Fco. Javier Muñoz Gall

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Utilidad de la medida del pH en el condensado de aire exhalado en el diagnóstico de asma ocupacional

IP: Mª Jesús Cruz Carmona
Collaborators: Mario Culebras Amigo, Fco. Javier Muñoz Gall, Ferran Morell Brotad
Funding agency: Instituto de Salud Carlos III
Funding: 15125
Reference: PI07/90086
Duration: 01/01/2008 - 30/06/2009

Asociación de los alelos HLA clase II y riesgo de susceptibilidad en el asma ocupacional inducida por sustancias de bajo peso molecular en una población española: Implicaciones diagnósticas y terapéuticas

IP: Mª Jesús Cruz Carmona
Collaborators: Fco. Javier Muñoz Gall, Jesus Castro Marrero, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 26837.8
Reference: PI06/0256
Duration: 01/01/2007 - 30/06/2010

Estudio clínico multicéntrico prospectivo con asignación aleatoria a grupos paralelos para comparar la eficacia de la adptación ambulatoria u hospitalaria a la ventilación meánica no invasiva domiciliaria en pacientes con insuficiencia respiratoria cróni

IP: Fco. Javier Muñoz Gall
Collaborators: -
Funding agency: SOC.ESPAÑOLA NEUMOLOGIA CIRUGIA TORACICA
Funding: 9000
Reference: SEPAR/02/2004
Duration: 01/01/2005 - 01/01/2007

Asma ocupacional en profesionales de peluquería: prevalencia, agentes causales y determinantes ambientales

IP: Fco. Javier Muñoz Gall
Collaborators: Ferran Morell Brotad, Maria Antonia Ramon Belmonte, Mª Jesús Cruz Carmona, Susana Gómez Olles
Funding agency: Instituto de Salud Carlos III
Funding: 53550
Reference: PI050100
Duration: 01/01/2006 - 31/12/2008

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Ma Irene Valenzuela Palafoll

Ma Irene Valenzuela Palafoll

Predoctoral researcher
Genetics Medicine
Read more
Verónica Villagrasa Araya

Verónica Villagrasa Araya

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Monica Anglada Baguena

Monica Anglada Baguena

Coordinador/a
Quality, Processes and Document Management
Digital Transformation and Quality Area
Read more
Albert Vilanova Baldellou

Albert Vilanova Baldellou

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.